Background: Frailty is a multidimensional syndrome characterized by loss of physiologic and cognitive reserve that heightens vulnerability. Frailty has been well described among elderly patients (i.e., 65 years of age or older), but few studies have evaluated frailty in nonelderly patients with critical illness. We aimed to describe the prevalence, correlates, and outcomes associated with frailty among younger critically ill patients. Methods: We conducted a prospective cohort study of 197 consecutive critically ill patients aged 50–64.9 years admitted to intensive care units (ICUs) at six hospitals across Alberta, Canada. Frailty was defined as a score ≥5 on the Clinical Frailty Scale before hospitalization. Multivariable analyses were used to evaluate factors independently associated with frailty before ICU admission and the independent association between frailty and outcome. Results: In the 197 patients in the study, mean (SD) age was 58.5 (4.1) years, 37 % were female, 73 % had three or more comorbid illnesses, and 28 % (n = 55; 95 % CI 22–35) were frail. Factors independently associated with frailty included not being completely independent (adjusted OR [aOR] 4.4, 95 % CI 1.8–11.1), connective tissue disease (aOR 6.0, 95 % CI 2.1–17.0), and hospitalization within the preceding year (aOR 3.3, 95 % CI 1.3–8.1). There were no significant differences between frail and nonfrail patients in reason for admission, Acute Physiology and Chronic Health Evaluation II score, preference for life support, or treatment intensity. Younger frail patients did not have significantly longer (median [interquartile range]) hospital stay (26 [9–68] days vs. 19 [10–43] days; p = 0.4), but they had greater 1-year rehospitalization rates (61 % vs. 40 %; p = 0.02) and higher 1-year mortality (33 % vs. 20 %; adjusted HR 1.8, 95 % CI 1.0–3.3; p = 0.039). Conclusions: Prehospital frailty is common among younger critically ill patients, and in this study it was associated with higher rates of mortality at 1 year and with rehospitalization. Our data suggest that frailty should be considered in younger adults admitted to the ICU, not just in the elderly. Additional research is needed to further characterize frailty in younger critically ill patients, along with the ideal instruments for identification.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1X68btz
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
▼
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
-
▼
Ιουνίου
(1110)
-
▼
Ιουν 05
(50)
- The impact of marital status at diagnosis on cance...
- Genetic alterations of differentiated thyroid carc...
- Sorafenib treatment in children with relapsed and ...
- Incidence and long-term outcome of postradiotherap...
- Effects of propolis and gamma-cyclodextrin on inte...
- Study Skills Inventory among Medical Students of P...
- Inappropriate statistical method in a parallel-gro...
- A feasibility study of implementing grip strength ...
- Effectiveness of management interventions for cont...
- Microenvironmental Control of Adipocyte Fate and F...
- Cellular Organization and Cytoskeletal Regulation ...
- Issue Cover (June 2016)
- Tridimensional finite element analysis of teeth mo...
- Ovarian malignancy unmasked by venous gangrene in ...
- The Trans-Pacific Partnership Agreement and health...
- Retrospective cohort analysis of healthcare claims...
- High tau levels in cerebrospinal fluid predict nur...
- We need to optimize piperacillin-tazobactam dosing...
- Rapid assessment of knowledge, attitudes, practice...
- A prospective multicenter cohort study of frailty ...
- Antiepileptic drug combinations not involving valp...
- The Reliability of Oral and Pharyngeal Dimensions ...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Changing Adjuvant Breast-Cancer Therapy with a Sig...
- Extending Aromatase-Inhibitor Adjuvant Therapy to ...
- Changing Adjuvant Breast-Cancer Therapy with a Sig...
- A Plea for Ecological Argument Technologies
- Χρόνιος πόνος και υποδοχείς της κανναβινόλης
- Φάρμακα για το λουμπάγκο
- Πόνοι στη μέση
- Πόνοι στη μέση και νευρογλοία
- Οι κανναβινοειδείς υποδοχείς
- Ο ρόλος της γλυκίνης στο λουμπάγκο
- Ο ρόλος της γλουταμάτης στον πόνο
- Health-related quality of life after maxillectomy:...
- Cross-cover of oral and maxillofacial surgery out-...
- Outcomes of treatment of fractures of the frontal ...
- Recording Mouse Ultrasonic Vocalizations to Evalua...
- The concurrent and predictive validity of the Dutc...
- The role of biofilm on orthopaedic implants: the “...
- Neural indices of phonemic discrimination and sent...
- Tumor Necrosis Factor-Like Weak Inducer of Apoptos...
- Errors as a Means of Reducing Impulsive Food Choice
- Assessing stability in mild and moderate Parkinson...
- Is age an independent risk factor for medical comp...
- Apoptosis-associated protein expression in human s...
- TWiV 392: Zika virus!
- Pimavanserin: First Global Approval
-
▼
Ιουν 05
(50)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Κυριακή 5 Ιουνίου 2016
A prospective multicenter cohort study of frailty in younger critically ill patients
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου